title: Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia.
abstract: Dispositional risk factors for developing the immune-type of heparin-induced thrombocytopenia (HIT) are yet unclear. This article presents a long-term follow-up of patients with HIT to define possible risk factors that may increase the risk of HIT. The clinical course of acute HIT was analyzed retrospectively in 52 patients with HIT. Thirteen patients died; 8 due to HIT. A follow-up investigation was performed in 28 of the remaining 39 patients 29 +/- 12 months after the onset of HIT, including genotyping for the factor V G1691A- and the prothrombin G20210A-mutation, measurement of antithrombin, protein C, protein S, factor VIII, and factor XII activity as well as the concentration of antiphospholipid antibodies. The results were compared to an age- and sex-matched control group. New thromboembolic events and re-exposure to heparin were also documented. No difference between patients and controls was observed concerning the factor V Leiden mutation, the prothrombin mutation, factor XII, antithrombin, protein S, or protein C deficiency and antiphospholipid antibodies. Increased factor VIII activity was found in 16 of 21 HIT patients compared to 4 of 21 controls (p=0.0005). New thromboembolic events developed in 5 patients within 9 months after HIT. One patient had been re-exposed to heparin 9 months after acute HIT without any complications. Increased factor VIII activity was frequently observed in patients in whom HIT developed. Thromboembolic complications within the first months after onset of HIT occurred often.
authors.affiliation: Department of Internal Medicine, Division of Angiology, University Hospital Frankfurt, Germany. Lindhoff-Last@em.uni-frankfurt.de
authors.forename: Edelgard
authors.initials: E
authors.lastname: Lindhoff-Last
authors.forename: Britta
authors.initials: B
authors.lastname: Wenning
authors.forename: Martina
authors.initials: M
authors.lastname: Stein
authors.forename: Frank
authors.initials: F
authors.lastname: Gerdsen
authors.forename: Rupert
authors.initials: R
authors.lastname: Bauersachs
authors.forename: Roland
authors.initials: R
authors.lastname: Wagner
mesh_terms: D000368:Aged; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D013923:Thromboembolism / Q000209:etiology; D019851:Thrombophilia / Q000097:blood / Q000175:diagnosis
chemical_list: D006493:Heparin